Biogen Idec, Inc. - SWOT Analysis

Biogen Idec, Inc. - SWOT Analysis
  • Report price : $ 125
  • Publication date : April 2008
  • Length : 27 pages

Get this Report Now !

Biogen Idec, Inc. - SWOT Analysis

Datamonitor's Biogen Idec, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Biogen Idec is engaged in the development, manufacturing, and commercialization of novel therapies in the areas of oncology, neurology and immunology. The company's key products include Avonex and Rituxan. The company primarily operates in the US and Europe. It is headquartered in Cambridge, Massachusetts and employs 3,750 people. The company recorded revenues of $2,683 million during the fiscal year ended December 2006, an increase of 10.8% over 2005. The operating profit of the company was $440 million during fiscal year 2006, an increase of 86.4% over 2005. The net profit was $217.5 million in fiscal year 2006, an increase of 35.3% over 2005.

Scope of the Report

- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available

RELATED REPORTS

CollaGenex Pharmaceuticals, Inc. - SWOT Analysis

CollaGenex Pharmaceuticals, Inc. - SWOT Analysis

  • $ 125
  • April 2008
  • 25 pages

Datamonitor's CollaGenex Pharmaceuticals, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines ...

Industries : Pharmaceutical | Countries : USA

Nastech Pharmaceutical Company Inc - SWOT Analysis

Nastech Pharmaceutical Company Inc - SWOT Analysis

  • $ 125
  • April 2008
  • 25 pages

Datamonitor's Nastech Pharmaceutical Company Inc - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue line ...

Industries : Pharmaceutical | Countries : USA

Pfizer Inc - SWOT Analysis

Pfizer Inc - SWOT Analysis

  • $ 125
  • April 2008
  • 45 pages

Datamonitor's Pfizer Inc - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Pfizer, ...

Industries : Pharmaceutical | Countries : USA

Santarus, Inc. - SWOT Analysis

Santarus, Inc. - SWOT Analysis

  • $ 125
  • April 2008
  • 23 pages

Datamonitor's Santarus, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Sant ...

Industries : Pharmaceutical | Countries : USA

Amgen Inc. - SWOT Analysis

Amgen Inc. - SWOT Analysis

  • $ 125
  • April 2008
  • 37 pages

Datamonitor's Amgen Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Amgen is ...

Industries : Pharmaceutical | Countries : USA

Insulin Delivery Systems Market Analysis (2007-2010)

Insulin Delivery Systems Market Analysis (2007-2010)

  • $ 1 400
  • January 2008
  • 250 pages

The research report “Insulin Delivery Systems Market Analysis (2007-2010)” by RNCOS gives an exhaustive analysis on the global insulin market and various Insulin delivery methods. The report investigates the market for various devices used for delivering insulin, including syringes, pens, pumps, ...

Industries : Medical Devices, Pharmaceutical | Countries : Egypt, Mexico, Brazil, USA, China, Japan, India, Pakistan, Russia, Germany

Live-Licensing and In-life testing: R and D Processes and Regulation for New Drugs, 2008-2020

Live-Licensing and In-life testing: R and D Processes and Regulation for New Drugs, 2008-2020

  • $ 2 501
  • January 2008
  • 250 pages

Visiongain predict that the current phase I to IV clinical testing process will eventually be selectively or wholly replaced by a system known as “in-life” testing or “live” licensing. Those proposals involve cumulative testing of the drug throughout its lifecycle. The industry would continu ...

Industries : Pharmaceutical | Countries : USA, Japan, Germany, United Kingdom

Sleep Disorders Market Analysis 2008-2018

Sleep Disorders Market Analysis 2008-2018

  • $ 2 501
  • March 2008
  • 250 pages

More than 80 sleep disorders have been identified. They affect over 200 million people worldwide. The report focuses on the market for following sleep disorders: Insomnia Restless legs syndrome (RLS) Narcolepsy and Obstructive Sleep Apnoea / Hypopnea Syndrome (OSAHS) The market penetration for insom ...

Industries : Pharmaceutical | Countries : USA, Japan, Germany, Spain, France, Italy, United Kingdom

The Antibacterial Drug Market Analysis 2008-2013

The Antibacterial Drug Market Analysis 2008-2013

  • $ 2 501
  • March 2008
  • 250 pages

This brand new market analysis by visiongain examines the prospects for antibacterial drugs from 2008-2013, including sales forecasts for leading pharmaceutical products. The antibacterial market is large in terms of disease area as well as the different drug classes used to treat these infections. ...

Industries : Pharmaceutical | Countries : USA

World Wound Care Markets 2008

World Wound Care Markets 2008

  • $ 3 300
  • January 2008
  • 250 pages

2008 has seen no decrease in attention on wound care products. The aging of the population and a constant demand for products that speed healing and improve outcomes drives the wound care industry. For market watchers, this makes for a dynamic market that has changed in recent years with biological ...

Industries : Pharmaceutical | Countries : Canada, USA, Japan

reportlinker.com © Copyright 2009. All rights reserved

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.